Pharmaceuticals — US sector stocks, live prices and news
Constituents · 30
- 1
Eli Lilly and Company Common StockLLY$1.06T
- 2
Johnson & Johnson Common StockJNJ$548B
- 3
Merck & Company, Inc. Common Stock (new)MRK$293B
- 4
Novartis AG Common StockNVS$270B
- 5
Novo Nordisk A/S Common StockNVO$149B
- 6
Pfizer, Inc. Common StockPFE$147B
- 7
Bristol-Myers Squibb Company Common StockBMY$115B
- 8
SanofiSNY$107B
- 9
GSK plc American Depositary Shares (Each representing two Ordinary Shares)GSK$102B
- 10
Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)TAK$49B
- 11
Teva Pharmaceutical Industries Limited Ordinary SharesTEVA$40B
- 12
Zoetis Inc. Class A Common StockZTS$34B
- 13
Jazz PharmaceuticalsJAZZ$15B
- 14
Elanco Animal Health Incorporated Common StockELAN$13B
- 15
Axsome TherapeuticsAXSM$12B
- 16
Dr. Reddy's Laboratories Ltd Common StockRDY$11B
- 17
Corcept Therapeutics IncorporatedCORT$8B
- 18
SupernusSUPN$3B
- 19
Prestige Consumer Healthcare Inc. Common StockPBH$2B
- 20
Nektar TherapeuticsNKTR$2B
- 21
Trevi TherapeuticsTRVI$2B
- 22
HUTCHMED (China) LimitedHCM$2B
- 23
Ocular TherapeutixOCUL$2B
- 24
Bausch Health Companies Inc. Common StockBHC$2B
- 25
ANI PharmaceuticalsANIP$2B
- 26
InnovivaINVA$2B
- 27
Perrigo Company plc Ordinary SharesPRGO$1B
- 28
HarrowHROW$1B
- 29
Wave Life SciencesWVE$1B
- 30
EyePointEYPT$1B
Latest Pharmaceuticals news · 12
Moderna Raises 2026 Growth Outlook, Putting Execution Ahead of Pipeline HypeNov 6, 2026
Pfizer Raises 2026 Outlook as Newer Products Grow 32% OperationallyNov 3, 2026
Eli Lilly Raises Sales Outlook, $91-$92 Billion Tests Pricing Trade-OffOct 29, 2026
S&P 500 Ex-AI Index Edges Ahead — What the 12.4% Gain SignalsOct 27, 2026
Novo, Wegovy Pill Switchers Lost Roughly 4% More Weight in Three MonthsSep 30, 2026
Novo Nordisk, post-Wegovy plan meets a 2032 patent cliffSep 21, 2026
Novo Nordisk rebrands to Novo as obesity-market share gap with Lilly widensSep 14, 2026
Novo Nordisk, STEP Young Opens a Pediatric Test for WegovySep 13, 2026
Pfizer Dividend Under Pressure as Payout Tops 100% and Cash Coverage TightensSep 13, 2026
Novartis Pelacarsen Miss Raises the Bar for Amgen and Eli LillySep 8, 2026
Eli Lilly, Regeneron Among First Seven in FDA's Manufacturing PreCheck Pilot — the Supply Chain Acceleration Markets Are UnderpricingJun 30, 2026
Medicare GLP-1 Coverage Starts July 1: LLY, NVO and the Awareness GapJun 29, 2026About Pharmaceuticals
The Pharmaceuticals sector includes 64 listed US companies with a combined market capitalization of $3.01T. Its largest constituent is Eli Lilly and Company Common Stock (LLY). Below are the biggest Pharmaceuticals stocks and the latest news across them.
What are the largest Pharmaceuticals stocks?
The biggest US Pharmaceuticals companies by market cap include Eli Lilly and Company Common Stock (LLY), Johnson & Johnson Common Stock (JNJ), Merck & Company, Inc. Common Stock (new) (MRK), Novartis AG Common Stock (NVS), Novo Nordisk A/S Common Stock (NVO). The full ranked list is shown above.
How big is the US Pharmaceuticals sector?
The Pharmaceuticals sector spans 64 listed US companies with a total market capitalization of about $3.01T.
Where can I see Pharmaceuticals news?
The latest stories across Pharmaceuticals companies are listed in the news section on this page, updated as they are published.
Live quotes update during US trading hours; the last close is shown otherwise. Market capitalization is aggregated from listed US companies and provided for information only — not investment advice.